Oxford-AstraZeneca COVID shot less effective against South African variant: study
British drugmaker AstraZeneca AZN.L said on Saturday its vaccine developed with the University of Oxford appeared to offer only limited protection against mild disease caused by the South African variant of COVID-19, based on early data from a trial.
from bdnews24.com - Home https://ift.tt/3rvbexy
from bdnews24.com - Home https://ift.tt/3rvbexy
No comments